Feedback (LSE:FDBK) ROCE %: -67.27% (As of Nov. 2025)


What is Feedback ROCE %?

Feedback LSE:FDBK ROCE % is -67.27% as of Nov. 2025. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Feedback's annualized ROCE % for the quarter that ended in Nov. 2025 was -67.27%.

Feedback  (LSE:FDBK) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Feedback ROCE % Related Terms

Feedback ROCE % Historical Data

* Premium members only.

The historical data trend for Feedback's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Feedback ROCE % Chart

Feedback Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -58.43 -26.48 -27.85 -39.86 -60.98

Feedback Semi-Annual Data
May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -43.05 -37.44 -41.74 -50.56 -67.27

Feedback ROCE % Calculation

Feedback's annualized ROCE % for the fiscal year that ended in May. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: May. 2025 )  (A: May. 2024 )(A: May. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: May. 2025 )  (A: May. 2024 )(A: May. 2025 )
=-4.211/( ( (8.339 - 0.694) + (6.754 - 0.589) )/ 2 )
=-4.211/( (7.645+6.165)/ 2 )
=-4.211/6.905
=-60.98 %

Feedback's ROCE % of for the quarter that ended in Nov. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Nov. 2025 )  (Q: May. 2025 )(Q: Nov. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Nov. 2025 )  (Q: May. 2025 )(Q: Nov. 2025 )
=-3.574/( ( (6.754 - 0.589) + (4.861 - 0.4) )/ 2 )
=-3.574/( ( 6.165 + 4.461 )/ 2 )
=-3.574/5.313
=-67.27 %

(1) Note: The EBIT data used here is two times the semi-annual (Nov. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -67.27% mean?
Feedback (LSE:FDBK) has a ROCE % of -67.27% as of Nov. 2025.
Is Feedback's ROCE % too high?
Feedback's current ROCE % is -67.27%.
How does Feedback's ROCE % compare to VEEV and BTSG?
Feedback's ROCE % of -67.27% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Feedback's current ROCE % is -67.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feedback stock overvalued right now?
Based on GuruFocus' analysis, Feedback (LSE:FDBK) is currently considered Possible Value Trap. The stock's GF Value™ is £0.14, compared to a current price of £0.07 — trading 49.3% below its estimated fair value. The current ROCE % is -67.27%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Feedback (LSE:FDBK), the current ROCE % is -67.27% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Feedback Business Description

Other Exchanges GZM0:Germany
Address 3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making, and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. Its operating segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa, a regulated communication platform for sharing clinical results and supporting multidisciplinary teamwork, and CareLocker, a patient-facing platform that provides access and control over diagnostic and clinical data.